Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2008-03-11
2008-03-11
Li, Ruixiang (Department: 1646)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S012200
Reexamination Certificate
active
07342097
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: WO 9110727 (1991-07-01), None
patent: WO 92010518 (1992-06-01), None
patent: WO 99/63088 (1999-12-01), None
Chen et al., Discordant protein and mRNA expression in lung adenocarcinomas. Molecular & Cellular Proteomics 1:304-313, 2002.
Hu et al., Analysis of genomic and proteomic data using advanced literature mining. Journal of Proteome Research 2:405-412, 2003.
Haynes et al., Proteome analysis: biological assay or data archive? Electrophoresis 19: 1862-1871, 1998.
King et al., Gene expression profile analysis by DNA microarrays. J. American Medical Assoc. 286:2280-2288, 2001.
Nagaraja et al., Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics. Oncogene 25: 2328-2338, 2006.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Dayhoff, Accession No. P—AAB65236, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
Dayhoff, Accession No. P—AAU12396, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker et al.
Dayhoff, Accession No. P—AAY66713, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. Baker et al.
Dayhoff, Accession No. BAB71240.1, Direct Submission, Submitted: Oct. 24, 2001, T. Isogai et al.
Dayhoff, Accession. P—AAG65898, WO 200172961-A2, Pub Date: Oct. 4, 2001, Agarwal et al.
GenBank, Accession No. P—AAF44199, WO 200073454-A1, Pub Date: Dec. 7, 2000, A. J. Ashkenazi et al.
GenBank, Accession No. P—AAZ65053, WO 9963088-A2, Pub Date: Dec. 9, 1999, K. Baker et al.
GenBank, Accession No. AX362397, WO 0208288-A, Pub Date: Jan. 31, 2002, K. P. Baker et al.
GenBank, Accession No. AX358904, WO 0193983-A, Pub Date: Dec. 13, 2001, K. P. Baker et al.
GenBank, Accession No. P—AAS21468, WO 200140466-A2, Pub Date: Jun. 7, 2001, K. P. Baker et al.
Chlemetson, K. J., Platelet Activation: Signal Transduction Via Membrane Receptors, Thrombosis and Haemostasis, vol. 74, No. 1, pp. 111-116, Jul. 1995.
De La Salle, C., et al., “Biochemical and Molecular Basis of Bernard-Soulier syndrome: a review”, Nouv. Rev. Fr. Hematol., vol. 37, pp. 215-222, 1995.
Kobe, Bostjan, et al., “The leucine-rich repeat: a versatile binding motif”, Trends Biochem. Sci., vol. 19, No. 10, pp. 415-421, Oct. 1994.
Kobe, Bostjan, et al., “Proteins with leucine-rich repeats”, Curr. Opin. Struct. Biol., vol. 5, No. 3, pp. 409-416, 1995.
Harris, P. C., et al., “Polycystic Kidney Disease 1: Identification and Analysis of the Primary Defect”, J. Am. Soc. Nephrol., vol. 6, No. 4, pp. 1125-1133, Oct. 1995.
Iozzo, R. V., “The Family of the Small Leucine-Rich Proteoglycans: Key Regulators of Matrix Assembly and Cellular Growth”, Crit. Reviews in Biochemistry and Molecular Biology, vol. 32, No. 2, pp. 141-174, 1997.
Miura, Y., et al., “RP105 and B cell apoptosis”, Nippon Rinsho (Japan), vol. 54, No. 7, pp. 1784-1789, Jul. 1996.
Suzuki, et al., “CDNA Cloning of a Novel Membrane Glycoprotein That is Expresses Specifically in Glial Cells in the Mouse Brain”, J. Biol. Chem., vol. 271, No. 37, pp. 22522-22527, 1996.
Tayar, N., et al., “Advances in the molecular understanding of gonadotropins-receptors interactions”, Mol. Cell Endocrinol., vol. 125, pp. 65-70, Dec. 1996.
Abe, N., et al., “An Increased High-Mobility Group A2 Expression Level is Associated with malignant Phenotype in Pancreatic Exocrine Tissue,”Br J Cancer—89(11):2104-9 (2003) Abstract.
Ando, M., et al., “Selective Apoptosis of Natural Killer-Cell Tumours by I-Asparaginase,”Br J Haematol., —130(6):860-8 (2005) Abstract.
Aust, G., et al., “Human Thyroid Carcinoma Cell Lines and Normal Thyrocytes: Expression and Regulation of Matrix Metalloproteinase Inhibitor-1 Messenger-RNA and Protein,”Thyroid—7(5):713-24 (1997) Abstract.
Barnes, V.L., et al., “Expression of Embryonic Fibronectin Isoform EIIIA Parallels Alpha-Smooth Muscle Actin in Maturing and Diseased Kidney,”J Histochem Cytochem.—47(6):787-98 (1999) Abstract.
Bea, S., et al., “BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphonas,”Cancer Res.—61(6):2409-12 (2001) Abstract.
Blaschke, V., et al., “Rapid Quantitation of Proinflammatory and Chemoattractant Cytokine Expression in Small Tissue Samples and Monocyte-Derived Dendritic Cells: Validation of a New Real-Time RT-PCR Technology,”J Immunol Methods. —246(1-2):79-90 (2000) Abstract.
Buckley, A.R., et al., “Butyrate-Induced Reversal of Dexamethasone Resistance in Autonomouse Rat Nb2 Lymphoma Cells,”Apoptosis. —2(6):518-28 (1997) Abstract.
Caberlotto, L. et al., “Alterations in Neuropeptide Y Levels and Y1 Binding Sites in the Flinders Sensitive Line Rats, A Genetic Animal Model of Depression,”Neurosci Lett.—265(3):191-4 (1999) Abstract.
Caberlotto, L., et al., “Neurokinin 1 Receptor and Relative Abundance of the Short and Long Isoforms in the Human Brain,”Eur J Neurosci.—17(9):1736-46 (2003) Abstract.
Choi, D., et al., “Characterization of Cyclin D2 Expression in Human Endometrium,”J Soc Gynecol Investig.—9(1):41-6 (2002) Abstract.
Couvelard, A., et al., “Human Chorionic Gonadotrophin Beta Expression in Malignant Barrett's Oesophagus,”Virchows Arch.—445(3):279-84 (2004) Abstract.
Dagenais, A., et al., “Downregulation of EnaC Activity and Expression by TNF-Alpha in Alveolar Epithelial Cells,”Am J. Physio Lung Cell Mol Physiol.—286(2):L301-11 (2004) Abstract.
De Boer, C.J., et al., “Involement of the CCNDI Gene in Hairy Cell Leukemia,”Ann Oncol.—7(3):251-6 (1996) Abstract.
Debieve, F., et al., “Inhibin and Activin Production and Subunit Expression in Human Placental Cells Cultured in Vitro,”Mol Hum Reprod.—6(8):743-9 (2000) Abstract.
Dong, Z., et al., “Expression of Membrane-Type Matrix Metalloproteinases 4, 5, and 6 in Mouse Corneas Infected with P. Aeruginosa,”Invest Opthalmol Vis Sci—42(13):3223- (2001) Abstract.
Duchrow, M., et al., “Assessment of Proliferative Activity in Colorectal Carcinomas by Quantitative Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR),”Cancer Invest.—19(6):588-96 (2001) Abstract.
Dyer, J., et al., “Molecular Characterisation of Carbohydrate Digestion and Absorption in Equine Small Intestine,”Equine Vet J.-34(4):349-58 (2002) Abstract.
Egwuagu, C.E., et al., “Suppressors of Cytokine Signaling Proteins are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance,”J Immunol.—168(7):3181-7 (2002) Abstract.
El-Ghrably, I.A., et al., “Intravitreal Invading Cells Contribute to Vitreal Cytokine Milieu in Proliferative Vitreoretinopathy,”Br J Opthalmol.—85(4):461-70 (2001) Abstract.
Eleore, L., et al., “Modulation of the Glutamatergic Receptors (AMPA and NMDA) and of Glutamate Vesicular Transporter 2 in the Rat Facial Nucleus after Axotomy,”Neuroscience—136(1):147-60 (2005) Abstract.
Forsberg, H., et al., “Altered Levels of Scavenging Enzymes in Embryos Subjected to a Diabetic Environment,”Free Radic Res.—24(6):451-9 (1996) Abstract.
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Smith Victoria
Wood William I.
Barnes Elizabeth M.
Dreger Ginger R.
Genentech Inc.
Kresnak Mark T.
Li Ruixiang
LandOfFree
PRO1309 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO1309 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO1309 polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2797653